본문 바로가기 주메뉴 바로가기
  • HOME
  • Public Relations
  • GC Cell News

GC Cell News

KISO Int’l Conference Successfully Takes Place
2018-10-25
대한통합암학회 국제학술대회 성료

The Korea Society of Integrative Oncology (KSIO) International Conference took place on October 14, 2018, bringing together world renowned researchers and specialists to discuss this year’s theme “Current Integrative Oncology.”

The conference featured the keynotes and sessions with renowned speakers in the field of immune cell therapies, including Prof. Ken Ishi, Osaka University, Japan; Dr. Frank Fan, Nanjing University, China; Dr. Gary Deng, Memorial Sloan Kettering Cancer Center, the U.S.; and Dr. Teruaki Sekine, GC Lympotec, Japan.

Dr. Teruaki Sekine is the founder of GC LympoTec, the Japanese subsidiary of GC Green Cell, who is widely known as the father of cancer immunotherapy and has been active in research as one of the top oncologists in the country.

At this year’s conference which focused on “Potentialities of Cell Immune Therapies,” Dr. Sekine said, “Until recently, immunotherapy was not the standard of care in oncology, but treatment with immune cells is now considered one of the most promising approaches in cancer treatment. I believe that immune cell-based immunotherapy will become the standard of care for patients with cancer in the near future.”

Based on the positive evaluation, GC Green Cross Cell remains committed to accelerating advances in cancer treatment as a global biotech company specializing in immunotherapy.

Next
The RWD of Immune cell-LC Injection has been announced in an international academic journal
Previous
GC Cell Entered into an Agreement of Cooperation to go to Russia